What type of study is this?

This is a Pre-Registered Trial study.

Comparison of T1 sensitivity to ferumoxytol at 0.55T versus 3T: a preclinical cardiac MRI study

View Full Paper

Ask AI

Bookmark

Authors

Preclinical analysis reveals 0.55T significantly enhances T1 sensitivity and reduces artifact severity in cardiac MRI.

0.55T demonstrated a 2.5-fold greater myocardial T1 sensitivity to ferumoxytol compared to 3T, enhancing diagnostic capabilities.
Significantly reduced susceptibility artifacts were noted at the lower field strength, improving image quality during assessments.
In-vivo analysis showed that measuring myocardial blood volume benefits from increased sensitivity at 0.55T, essential for identifying ischemia.
This research highlights the potential for dose reduction of ferumoxytol while maintaining diagnostic quality in cardiac assessments.

Zeynali et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark